» Articles » PMID: 10491411

IL-12-induced IFN-gamma is Dependent on Caspase-1 Processing of the IL-18 Precursor

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1999 Sep 24
PMID 10491411
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

IL-12 and IL-18 are IFN-gamma-inducing cytokines. In the present study, the role of endogenous IL-18 in the induction of IFN-gamma by IL-12 was investigated in mice. In the presence of a specific inhibitor of caspase-1 (also known as IL-1beta-converting enzyme, or ICE) IL-12-induced IFN-gamma from splenocytes was reduced by 85%. Using splenocytes from ICE-deficient mice, IL-12-induced IFN-gamma was reduced by 80%. However, the role of ICE was not through processing and release of IL-1beta. Neutralizing anti-IL-18 IgG reduced IL-12-induced IFN-gamma in splenocytes by 85%. Splenocytes cultured in vitro spontaneously released IL-18 into the extracellular compartment over time. Extracellular levels of IL-18 significantly correlated with IL-12-induced IFN-gamma and were reduced in cells obtained from ICE-deficient mice. In vivo, IL-12 administration increased circulating levels of IL-18 in wild-type mice but not in ICE-deficient mice. Both neutralization of IL-18 and ICE deficiency significantly reduced induction of circulating IFN-gamma in mice receiving IL-12. The IL-18 precursor was constitutively expressed in the livers and spleens of untreated mice. Furthermore, administration of IL-12 significantly increased liver-associated IL-18 levels. These data demonstrate that endogenous, ICE-cleaved IL-18 significantly contributes to induction of IFN-gamma by IL-12.

Citing Articles

[Nodakenin ameliorates TNBS-induced experimental colitis in mice by inhibiting pyroptosis of intestinal epithelial cells].

Huang J, Yin L, Niu M, Geng Z, Zuo L, Li J Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):261-268.

PMID: 40031970 PMC: 11875862. DOI: 10.12122/j.issn.1673-4254.2025.02.07.


Inflammasome activation in patients with Kaposi sarcoma herpesvirus-associated diseases.

Lage S, Ramaswami R, Rocco J, Rupert A, Davis D, Lurain K Blood. 2024; 144(14):1496-1507.

PMID: 38941593 PMC: 11474434. DOI: 10.1182/blood.2024024144.


Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of ()-DS-ONJ.

Gomez-Jaramillo L, Cano-Cano F, Sanchez-Fernandez E, Ortiz Mellet C, Garcia-Fernandez J, Alcala M Int J Mol Sci. 2022; 23(15).

PMID: 35955585 PMC: 9368839. DOI: 10.3390/ijms23158450.


Role for IL-1 Family Cytokines in Fungal Infections.

Griffiths J, Camilli G, Kotowicz N, Ho J, Richardson J, Naglik J Front Microbiol. 2021; 12:633047.

PMID: 33643264 PMC: 7902786. DOI: 10.3389/fmicb.2021.633047.


Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications.

Donate-Correa J, Ferri C, Sanchez-Quintana F, Perez-Castro A, Gonzalez-Luis A, Martin-Nunez E Front Med (Lausanne). 2021; 7:628289.

PMID: 33553221 PMC: 7862763. DOI: 10.3389/fmed.2020.628289.


References
1.
Black R, Kronheim S, Cantrell M, Deeley M, March C, Prickett K . Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem. 1988; 263(19):9437-42. View

2.
Lauw F, Dekkers P, Te Velde A, Speelman P, Levi M, Kurimoto M . Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis. 1999; 179(3):646-52. DOI: 10.1086/314636. View

3.
Thornberry N, Peterson E, Zhao J, Howard A, Griffin P, Chapman K . Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry. 1994; 33(13):3934-40. DOI: 10.1021/bi00179a020. View

4.
Miller B, Krasney P, Gauvin D, Holbrook K, Koonz D, Abruzzese R . Inhibition of mature IL-1 beta production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1 beta converting enzyme. J Immunol. 1995; 154(3):1331-8. View

5.
Orange J, Salazar-Mather T, Opal S, Spencer R, Miller A, McEwen B . Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med. 1995; 181(3):901-14. PMC: 2191920. DOI: 10.1084/jem.181.3.901. View